Thanks to the FEBS for awarding me a YSF travel grant!
@febspress.bsky.social
#FEBS2025 #BiochemEvent
Thanks to the FEBS for awarding me a YSF travel grant!
@febspress.bsky.social
#FEBS2025 #BiochemEvent
🌟 Highlights:
💡 Insightful talks given by students, postdocs and PIs
❓ Q&A from ECRs encouraged (thanks for my honourable mention for participation!)
🧫 Broad cell biology topics and methodology
💊 Clinical perspectives alongside fundamental research
🌟 Highlights:
💡 Insightful talks given by students, postdocs and PIs
❓ Q&A from ECRs encouraged (thanks for my honourable mention for participation!)
🧫 Broad cell biology topics and methodology
💊 Clinical perspectives alongside fundamental research
🎯 Biomechanical signatures & potential targets in cancer
🧬 Rho and Cdc42 regulation via PTMs, localisation & degradation in cancer and immunodeficiencies
⚙️ Nuclear force feedback loops via Rnd3 modulate actomyosin tension
@biochemsoc.bsky.social #BiochemEvent
🎯 Biomechanical signatures & potential targets in cancer
🧬 Rho and Cdc42 regulation via PTMs, localisation & degradation in cancer and immunodeficiencies
⚙️ Nuclear force feedback loops via Rnd3 modulate actomyosin tension
@biochemsoc.bsky.social #BiochemEvent
Looking forward to Session 6 kicked off by @vickysanzmoreno.bsky.social!
@biochemsoc.bsky.social #BiochemEvent
Looking forward to Session 6 kicked off by @vickysanzmoreno.bsky.social!
@biochemsoc.bsky.social #BiochemEvent
🧬 Lipid sensing, β-catenin, and phosphorylation reshape GTPase signalling
⚙️ Mechanical forces & trafficking: nuclear F-actin, actin-Rab27a, plexins, and COL1
⚡️Cancer cell adaptation through RhoA/NFAT, Rac1 SUMOylation, and KRAS rewiring
@biochemsoc.bsky.social #BiochemEvent
🧬 Lipid sensing, β-catenin, and phosphorylation reshape GTPase signalling
⚙️ Mechanical forces & trafficking: nuclear F-actin, actin-Rab27a, plexins, and COL1
⚡️Cancer cell adaptation through RhoA/NFAT, Rac1 SUMOylation, and KRAS rewiring
@biochemsoc.bsky.social #BiochemEvent
⛓️ Tri-complex inhibitor as molecular glue for oncogenic RAS
💊 Combining inhibitors to combat KRAS-driven cancer
🎯 p120RasGAP molecular glue targeting RAS
🔢 Mathematical modelling to study RAS activity
🧐 RAS/RAL, Cdc42, RhoG, RAC1, EPAC2, RalGAP…
@biochemsoc.bsky.social #BiochemEvent
⛓️ Tri-complex inhibitor as molecular glue for oncogenic RAS
💊 Combining inhibitors to combat KRAS-driven cancer
🎯 p120RasGAP molecular glue targeting RAS
🔢 Mathematical modelling to study RAS activity
🧐 RAS/RAL, Cdc42, RhoG, RAC1, EPAC2, RalGAP…
@biochemsoc.bsky.social #BiochemEvent
🧬 RAP1GDS1 isoform regulates KRAS signalling & lysosomal function in lung adenocarcinoma
❓Oncogenic KRAS may not alter Akt/ERK pathways
☠️ p190RhoGAP paralogs show synthetic lethality in endometrial cancer
@biochemsoc.bsky.social #BiochemEvent
🧬 RAP1GDS1 isoform regulates KRAS signalling & lysosomal function in lung adenocarcinoma
❓Oncogenic KRAS may not alter Akt/ERK pathways
☠️ p190RhoGAP paralogs show synthetic lethality in endometrial cancer
@biochemsoc.bsky.social #BiochemEvent
⚙️ “Branchgetic” Ras mutations indicate effector selection
🔬 RAF biosensors to monitor acivity in live cells
💥 C2 domain boosts RasGAP activity
💊 RhoB-Ral complex a target for EGFR TK inhibition?
@biochemsoc.bsky.social #BiochemEvent
⚙️ “Branchgetic” Ras mutations indicate effector selection
🔬 RAF biosensors to monitor acivity in live cells
💥 C2 domain boosts RasGAP activity
💊 RhoB-Ral complex a target for EGFR TK inhibition?
@biochemsoc.bsky.social #BiochemEvent
✨ unpicking Ras effector binding in different tissues
✨ developing RAF based biosensors
✨ C2 domains and GAP functionality
✨ how RhoB and Ral affect EGFT therapy in lung cancer
@Biochemsoc #BiochemEvent
✨ unpicking Ras effector binding in different tissues
✨ developing RAF based biosensors
✨ C2 domains and GAP functionality
✨ how RhoB and Ral affect EGFT therapy in lung cancer
@Biochemsoc #BiochemEvent
🧫 Overcoming RAS resistance: biobanking & precision medicine
💊 Adaptive immunity could enhance KRAS inhibitor activity
🔬 Organoids reveal allele-specific tumour growth
💥 Plus ARL15, RhoGDI1, RalGEF, SOS1/2 & proteomics pipelines
@biochemsoc.bsky.social #BiochemEvent
🧫 Overcoming RAS resistance: biobanking & precision medicine
💊 Adaptive immunity could enhance KRAS inhibitor activity
🔬 Organoids reveal allele-specific tumour growth
💥 Plus ARL15, RhoGDI1, RalGEF, SOS1/2 & proteomics pipelines
@biochemsoc.bsky.social #BiochemEvent
⛓️ Mapping KRAS interactomes in organoid models
🧬 Isoform-specific KRAS vulnerabilities: one mutation, big difference
🔬 Novel tool tracks Ras mutation dynamics in vivo
✨ And a reminder that clear science communication empowers patients!
@biochemsoc.bsky.social #BiochemEvent
⛓️ Mapping KRAS interactomes in organoid models
🧬 Isoform-specific KRAS vulnerabilities: one mutation, big difference
🔬 Novel tool tracks Ras mutation dynamics in vivo
✨ And a reminder that clear science communication empowers patients!
@biochemsoc.bsky.social #BiochemEvent
@biochemsoc.bsky.social
#BiochemEvent
@biochemsoc.bsky.social
#BiochemEvent
I look forward to hearing about and discussing the latest research in the area as well as presenting my own PhD work about Arf proteins!
I look forward to hearing about and discussing the latest research in the area as well as presenting my own PhD work about Arf proteins!
Big thanks to @biologists.bsky.social & @bscb-official.bsky.social for the opportunity!
📸 Full post and photos on my LinkedIn
Big thanks to @biologists.bsky.social & @bscb-official.bsky.social for the opportunity!
📸 Full post and photos on my LinkedIn